Home › Migraine › Pennsylvania
Migraine clinical trials in Pennsylvania
8 studies for Migraine are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 1
Ages 6 to 11 · All sexes · Updated Sep 28, 2026 · NCT06995729MMA Embolization for Refractory Chronic Migraine
- Thomas Jefferson University Hospital, Philadelphia
Recruiting
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT06735833Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Clario, Philadelphia
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- The Children's Hospital of Philadelphia /ID# 270842, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 270854, Scottdale
- Frontier Clinical Research - Smithfield /ID# 270849, Smithfield
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 22, 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Children's Hospital of Philadelphia, Philadelphia
Recruiting
Ages 10 to 17 · All sexes · Updated Sep 21, 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- University of Pennsylvania, Philadelphia
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Children's Hospital of Philadelphia - Main /ID# 232487, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 231913, Scottdale
- Frontier Clinical Research - Smithfield /ID# 231912, Smithfield
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Lehigh Center for Clinical Research, Allentown
- Clinical Research Philadelphia, Philadelphia
- Preferred Primary Care Physicians, Inc., Pittsburgh
- and 2 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.